- Global Operation
- Contract Manufacturing
Neufil® (Filgrastim BP) is a Granulocyte Colony-Stimulating Factor (G-CSF) analog used to stimulate the proliferation and differentiation of granulocytes. It is produced by recombinant DNA technology. The gene for human granulocyte colony-stimulating factor is inserted into the genetic material of Escherichia coli. The G-CSF then produced by E.coli is only slightly different from G-CSF naturally made in humans.
Cancer patients receiving myelosuppressive chemotherapy, patients with acute myeloid leukemia receiving induction or consolidation chemotherapy, cancer patients receiving bone marrow transplantation, cancer patients undergoing peripheral blood progenitor cell collection and chemotherapy, patients with severe chronic neutropenia.
Neufil®: Each box contains one pre-filled syringe containing Filgrastim BP 30MU (300mcg/0.5ml)